Bheka ifayela lethu leCancer ukuze wazi okuyinhloko Izincomo on ukuvimbela umdlavuza usebenzisa imikhuba yokuphila :

- idla izithelo nemifino eyanele;

– ube nokudla okulinganiselayo fat;

– gwema ukweqisa ama-kilojoule;

– ukusebenza;

- Akubhenywa;

- njll.

Bheka futhi isigaba se-Complementary Approaches (ngezansi).

La ICanada Cancer Society imema abesilisa abaneminyaka engaphezu kuka-50 ukuthi bakhulume nodokotela wabo mayelana nengozi yabo yokuba nomdlavuza wendlala yesinye kanye nokufaneleka screening¹¹.

Two ukuhlolwa ingasetshenziswa odokotela ukuzama bona kusenesikhathi umdlavuza wendlala yesinye emadodeni angazange azikho izimpawu :

- the Ukuthinta i-rectal;

- the ukuhlolwa kwe-prostate ethize ye-antigen (APS).

Nokho, ukusetshenziswa kwabo kuyimpikiswano futhi iziphathimandla zezokwelapha azincomi ukutholwa kusenesikhathi emadodeni angenazo izimpawu.^{10, I-38}. Akuqiniseki ukuthi kuthuthukisa amathuba okusinda futhi andise ubude bempilo. Ngakho-ke kungenzeka ukuthi, iningi labantu, izingozi (ukukhathazeka, ubuhlungu kanye nemiphumela engenzeka uma kwenzeka ukuhlolwa okuphelele kusetshenziswa i-biopsy) kunezinzuzo screening.

• Izithako ze-Vitamin D. Ngenxa yemiphumela yezifundo ezehlukene, iCanadian Cancer Society isincome ukuthi abantu baseCanada, kusukela ngo-2007, bathathe 25µg (1 IU) ngosuku vitamin D ekwindla nasebusika⁴⁰. Ukudla okunjalo kwevithamini D kunganciphisa ingozi yomdlavuza wendlala yesinye kanye neminye imidlavuza. Inhlangano iphakamisa ukuthi abantu abane izingozi amazinga aphezulu okuntuleka kukavithamini D - okuhlanganisa abantu abadala, abantu abanebala elimnyama lesikhumba, kanye nabantu abangavamile ukuzichaya elangeni - benza okufanayo unyaka wonke.

  esasizizwa. Ochwepheshe abaningana bakholelwa ukuthi isikhundla seCanadian Cancer Society sihlala siqinile kakhulu maqondana nobufakazi besayensi. Kunalokho, batusa umthamo wansuku zonke we 2 IU kuya ku-000 IU i-vitamin D3. Ehlobo, umthamo ungancishiswa, inqobo nje uma uzichaya elangeni njalo (ngaphandle kokuvikela ilanga, kodwa ngaphandle kokushiswa yilanga).

• I-Finasteride (yengozi enkulu yomdlavuza we-prostate). I-Finasteride (i-Propecia®, i-Proscar®), isidakamizwa esiboniswa kuqala ukwelapha i-benign prostatic hyperplasia kanye nempandla, ingase futhi isize ekuvimbeleni umdlavuza wendlala yesinye. Le 5-alpha-reductase inhibitor, a e, ivimbela ukuguqulwa kwe-testosterone ku-dihydrotestosterone, uhlobo olusebenzayo lwe-hormone ngaphakathi kwe-prostate.

  Ngesikhathi socwaningo olukhulu⁹, abacwaningi babeqaphele ukuhlobana phakathi kokuthatha i-finasteride kanye nokutholwa kakhudlwana kohlobo olubi lomdlavuza wendlala yesinye. I-hypothesis yokuthi i-finasteride inyusa ubungozi bomdlavuza oyingozi we-prostate iye yaphikiswa. Kuyaziwa manje ukuthi ukutholakala kwalolu hlobo lomdlavuza kube lula ukuthi usayizi we-prostate unciphile. I-prostate encane isiza ukubona izimila.

• Le i-dutasteride (I-Avodart®), umuthi ongokwesigaba esifanayo njenge-finasteride, kuthiwa unomphumela wokuvimbela ofana nalowo we-finasteride. Yilokhu okubonisa imiphumela yocwaningo olwanyatheliswa ngo-2010¹².

  Okubalulekile. Qinisekisa ukuthi udokotela ohumusha ukuhlolwa kwegazi kwe-prostate-specific antigen (I-APS ou PSA) uyazi ngokwelashwa nge-finasteride, eyehlisa amazinga e-PSA.